CARBOGEN AMCIS invests over CHF 100M in Switzerland and France

CARBOGEN AMCIS announces two expansion projects: a new API manufacturing facility in Hunzenschwil, Switzerland (operational by summer 2024) and a new parenteral drug product facility in Riom, France (construction starts January 2021). Total investment exceeds CHF 100 million.

“After years of growth, it’s exciting to have reached our current production limits and to be able to expand our facilities and grow our capacity.”carbogen-amcis.com

• 1 source
• carbogen-amcis.comCARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and FranceAug 17, 2020

Summarized from public sources; check the original articles before acting on it.